Gene Query: TAX1BP3

Dataset Description Geneva Score
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 57.61
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 46.04
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 46.04
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 42.87
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 40.65
Effect of BMP inhibition or stimulation of primary human keratinocytes 39.89
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 39.89
LNCaP treated with iBET 37.8
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 35.49
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 35.49
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 31.29
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 29.44
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 29.09
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 27.02
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 26.8
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 25.87
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 25.37
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 25.37
RNA-seq of IL-4 stimulated human keratinocytes 25.18
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 25.08
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 25.08
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 25.03
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 25.02
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 24.05
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 23.87
Rorc disruption in human FG pancreatic cancer cells 23.51
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 22.65
AR-independent prostate cancer is sustained through FGF signaling 22.64
G-quadruplex structures mark human regulatory chromatin 22.55
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 22.41
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 22.06
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 22.05
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 21.97
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 21.97
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 21.81
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 21.81
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 21.0
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 20.97
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 20.88
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 20.71
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 20.56
20.46
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 20.43
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 20.43
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 20.38
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 19.77
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 19.68
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 19.61
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 19.48
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 19.48
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 19.36
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 18.99
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 18.99
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 18.97
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 18.77
Effect of Influenza virus infection on lncRNA expression in A549 cells 18.75
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 18.59
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 18.51
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 18.04
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 17.71
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 17.36
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 17.21
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 17.14
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 17.07
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 16.89
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 16.81
Ebola virus (EBOV) infection of ARPE-19 cells 16.7
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 16.44
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 16.32
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 16.3
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 16.3
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 16.25
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 16.25
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 16.03
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 15.93
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 15.84
Nucleoporin-mediated regulation of cell identity genes 15.8
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 15.63
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 15.59
DJ-1 is dispensable for human stem cell homeostasis 15.53
RNAseq analysis of ESRP regulated splicing events in prostate cancer 15.51
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 15.44
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 15.38
The human blood-nerve barrier transcriptome 15.22
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 15.04
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 15.04
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 14.97
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 14.93
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 14.89
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 14.89
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 14.85
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 14.83
NHLRC1 re-expression in cancer cells 14.81
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 14.56
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 14.56
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 14.52
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 14.49
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 14.47
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 14.42
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 14.36
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 14.31
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 14.2
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 14.16
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 14.1
RNA-seq analysis of BAP1-depleted uveal melanoma cells 14.09
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 14.07
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 14.06
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 14.05
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 14.0
FOXD3 is a novel tumor suppressor in lung cancer 14.0
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 13.94
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 13.94
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 13.9
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 13.9
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 13.9
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 13.89
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 13.77
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 13.77
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 13.77
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 13.76
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 13.62
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 13.58
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 13.58
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 13.53
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 13.34
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 13.28
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 13.28
Mechanistic Model-Guided Study of Embryonic Morphogenesis 13.18
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 13.09
RNA-seq analyisis of PUM2 knockout cells 13.05
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 12.92
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 12.89
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 12.86
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 12.82
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 12.58
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 12.54
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 12.47
Aneuploidy-induced cellular stresses limit autophagic degradation. 12.43
RNA sequencing with KSHV infection and enrichment for circular RNAs 12.41
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 12.35
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 12.35
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 12.25
An integrative analysis of non-coding regulatory DNA variations associated with autism 12.21
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 12.21
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 12.16
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 12.13
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 12.13
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 12.05
BET bromodomain inhibition 12.01
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 12.01
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 11.99
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 11.99
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 11.99
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 11.99
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 11.91
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 11.82
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 11.81
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 11.81
Differential expression of genes in AD169-infected MRC5. 11.73
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 11.72
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 11.66
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 11.63
Total RNA sequencing of WT intestinal orgaonids. 11.56
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 11.53
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 11.47
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 11.44
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 11.43
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 11.41
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 11.34
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 11.34
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 11.25
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 11.15
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 11.15
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 11.14
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 11.13
Morphological and molecular characterization of human dermal lymphatic collectors 11.02
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 10.97
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 10.97
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 10.97
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 10.97
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 10.94
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 10.89
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 10.82
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 10.82
Tracing Enhancer Networks using Epigenetic Traits (TENET) 10.79
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 10.76
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 10.71
RNA-seq analysis of the human fetal kidney. 10.71
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 10.64
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 10.64
RNA-seq of human aneuploid cell lines with Trisomy 21 10.58
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 10.51
Functional role of CPPED1 in trophoblasts. 10.51
scRNASeq analysis of cycling cardiomyocytes 10.5
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 10.48
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 10.48
IDH3a KO RNA-seq 10.46
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 10.44
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 10.44
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 10.4
Evolution of a transcriptional regulator from a transmembrane nucleoporin 10.4
RNA-seq in HepG2 and IMR90 cells 10.4
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 10.39
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 10.39
Transcriptome profiling of Normal and Cancerous Prostate Cells 10.38
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 10.32
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 10.31
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 10.29
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 10.27
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 10.26
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 10.17
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 9.96
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 9.96
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 9.96
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 9.95
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 9.92
Postnatal lipids drive hepatocyte maturation 9.91
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 9.9
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 9.85
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 9.81
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 9.81
hnRNP C is a key regulator of protein synthesis in mitosis 9.81
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 9.78
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 9.76
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 9.74
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 9.73
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 9.71
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 9.7
METTL3 promotes translation in human cancer cells 9.68
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 9.67
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 9.63
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 9.61
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 9.56
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 9.54
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 9.53
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 9.51
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 9.47
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 9.47
RNAseq Analysis in glioblastoma cells treated with Mepazine 9.37
Pharmacologic inhibition of STAT5 in AML 9.35
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 9.3
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 9.3
Gene expression profiling of human and murine in vitro muscle differentiation 9.25
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 9.22
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 9.18
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 9.13
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 9.11
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 9.1
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 9.04
Active translatome profiling with RiboLace in MCF7 cells 9.02
Cell responses to dysregulated VZV-induced cell-cell fusion 9.02
Tpl-2 small molecule project 8.99
Tpl-2 and MEK small molecule inhibitors 8.99
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 8.94
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 8.92
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 8.91
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 8.91
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 8.9
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 8.9
Identification of transcription start sites for human A549 cell line using ReCappable-seq 8.87
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 8.87
Transcriptome analysis in Neobractatin treated cells 8.86
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 8.84
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 8.84
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 8.8
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 8.75
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 8.74
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 8.71
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 8.68
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 8.68
Oncogenic MYC induces a dependency on the spliceosome in human cancer 8.62
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 8.62
Modeling Familial Cancer with iPSC Approaches 8.55
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 8.43
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 8.41
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 8.4
Genome-wide analysis of Dengue virus 2 infected cells 8.39
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 8.35
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 8.32
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 8.32
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 8.32
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 8.26
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 8.21
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 8.2
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 8.19
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 8.16
iPSC-Derived Cholangiocytes 7.96
Identifying the molecular mode of action of itraconazole in colorectal cancer 7.91
Exploring the RNA landscape of endothelial exosomes 7.91
Integrin signaling regulates YAP/TAZ to control skin homeostasis 7.91
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 7.85
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 7.83
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 7.82
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 7.82
RNAseq of T-ALL upon long non coding rna purturbation 7.82
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 7.81
Cajal bodies are linked to genome conformation [RNA-Seq] 7.79
Cajal bodies are linked to genome conformation 7.79
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 7.73
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 7.62
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 7.52
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 7.49
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 7.49
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 7.48
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 7.47
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 7.44
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 7.44
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 7.4
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 7.35
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 7.32
Regulatory network controlling tumor-promoting inflammation in human cancers 7.28
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 7.28
RNA-Seq from human ILC transitional populations 7.26
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 7.26
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 7.24
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 7.18
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 7.16
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 7.04
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 6.93
RNA seq with AML (NB4) cells upon FTO inhibition 6.93
Conservative alteration of chromosomal expression pattern across human solid tumor types 6.91
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 6.9
Role of FGFR1 in neuronal devlopment 6.88
Expression profiles of the four human major ectodermal lineages 6.73
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 6.68
Gene expression analysis of human liver progenitor-like cells in culture 6.68
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 6.67
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 6.66
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 6.66
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 6.66
Expression by CD133+ cells isolated from the adult human exocrine pancreas 6.64
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 6.62
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 6.61
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 6.61
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 6.52
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 6.38
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 6.33
DAOY-Notch1/Notch2 knockout: transcriptome comparison 6.23
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 6.2
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 6.15
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 6.12
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 6.12
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 6.11
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 6.02
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 5.97
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 5.91
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 5.9
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 5.84
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 5.79
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 5.74
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 5.71
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 5.69
RNA editing in nascent RNA affects pre-mRNA splicing 5.62
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 5.58
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 5.47
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 5.47
Toxoplasma gondii infection of human retinal pigment epithelial cells 5.46
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 5.43
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 5.3
TOP2B disturbed the quality of human oocytes with advanced maternal age 5.26
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 5.22
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 5.14
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 5.14
The cohesin complex prevents Myc-induced replication stress 5.12
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 5.07
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 5.03
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 4.95
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 4.93
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 4.82
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 4.82
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 4.82
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 4.82
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 4.81
PGE2 mediated gene expression changes in human cervical stromal cells 4.8
RNA-seq differential expression studies: more sequence, or more replication? 4.74
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 4.64
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 4.61
Gene expression changes in human melanoma cell lines compared to primary melanocytes 4.59
Gene expression profile difference among renal location in a stone former 4.58
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 4.57
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 4.41
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 4.41
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 4.29
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 3.97
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 3.96
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 3.96
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 3.94
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.93
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 3.92
miR-93 Targets in Human Endothelial Cells 3.87
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 3.86
circNFIB suppresses lymphatic metastasis of pancreatic cancer 3.83
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 3.79
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  3.78
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 3.67
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 3.67
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 3.63
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 3.6
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 3.6
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 3.56
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 3.56
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 3.5
A single-cell transcriptome atlas of the human pancreas 3.48
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 3.46
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 3.46
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 3.45
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 3.45
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 3.45
p63 controls the enhancer landscape during keratinocyte differentiation 3.44
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 3.38
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 3.38
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 3.34
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 3.34
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 3.28
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 3.25
SF3B1 Degron knockdown RNA-seq 3.24
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 3.24
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 3.24
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 3.17
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 3.12
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 3.08
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 3.06
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.94
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.94
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.85
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 2.79
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 2.73
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.72
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 2.71
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 2.7
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 2.54
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 2.46
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 2.46
Human ovarian granulosa cell transcriptome 2.19
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 2.17
Transcriptome analysis of kidney organoids 2.12
RNA seq_PDX2_SHP099 2.1
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 2.05
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 2.01
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 2.01
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 2.01
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 2.0
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 1.95
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 1.84
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 1.82
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 1.75
MRTF activates TEAD-YAP target gene expression 1.74
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 1.74
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 1.74
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 1.56
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 1.53
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.53
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.53
Ribosomal protein RPL26 is the principal target of UFMylation 1.51
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.51
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 1.46
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 1.46
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 1.43
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 1.43
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 1.33
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 1.28
Gene expression analysis of human adenomas. 1.18
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 1.14
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 1.14
Dermal endothelial cells of type 2 diabetic patients 1.07
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 1.04
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 1.04
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.94
RNAseq of cell lines with knocked in ESR1 mutations 0.84
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 0.83
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.8
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 0.78
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 0.78
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 0.78
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.76
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.73
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.73
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.67
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 0.66
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.66
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.65
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.59
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 0.58
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 0.56
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.55
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.54
Finding missing proteins from epigenetically manipulated human cells 0.52
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.5
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.35
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.35
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 0.3
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 0.28
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 0.16
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 0.15
6mer seed toxicity in viral microRNAs 0.11
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.1
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.1
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 0.09
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 0.08
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.07


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation